Evidence map›Paper›PMID 36517325›Full record

ArticleVaccine2023

Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway.

Ida Henriette Caspersen, Lene K Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, Per Magnus, Lill Trogstad

Abstract readCase Reports
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Prospective Study of the Relationship of COVID-19 Vaccination to Menstrual Cycle Characteristics in Adolescent Girls.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ida Henriette CaspersenCentre for Fertility and Health, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway. Electronic address: ida.henriette.caspersen@fhi.no.
Lene K JuvetDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Berit FeiringDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Ida LaakeDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Anna Hayman RobertsonDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Siri MjaalandDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Per MagnusCentre for Fertility and Health, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.
Lill TrogstadDivision of Infection Control, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BNT162 VaccineCOVID-19AdolescentChildCohort StudiesCOVID-19 VaccinesFemaleHumansMenstruation DisturbancesBNT162 VaccineCOVID-19 Vaccines

Identifiers

PMID36517325
PMCPMC9715483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.